Amplifon published GN Hearing valuation documents. October 29 concerns Amplifon stock

Published on 10/21/2026 at 10:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half 2026 revenue rose 1.30 percent to EUR 1.19 billion at constant rates. Amplifon stock costs EUR 12.77 on October 21, 2026.

Upcoming corporate decision

Amplifon published GN Hearing valuation documents on October 8, 2026.
First-half 2026 revenue rose 1.30 percent to EUR 1.19 billion at constant exchange rates.
Amplifon stock trades at EUR 12.77 at 10:38 a.m. CEST at Lang & Schwarz on October 21, 2026.
The third-quarter report and shareholder meeting are scheduled for October 29, 2026.

Aquarellmalerei der Mailänder Skyline mit Dom in weichen Pastelltönen — Aquarellgemälde der Mailänder Skyline symbolisiert den Hauptsitz von Amplifon S.p.A., ISIN IT0004056880, italienischer Gesundheitskonzern, Illustration mit AI erstellt.

Amplifon (ISIN IT0004056880) was trading at EUR 12.77 at Lang & Schwarz on October 21, 2026 at 10:38 a.m. CEST. The company published valuation documents connected with its planned GN Hearing transaction on October 8, 2026, according to Amplifon Corporate.

Operating figures improve

Amplifon's first-half 2026 revenue reached EUR 1.19 billion, up 1.30 percent at constant exchange rates, while organic growth reached 3.50 percent. The figures were reported by Capital.com on September 30, 2026, citing Amplifon's first-half results.

Adjusted EBITDA rose 3.60 percent to EUR 298.0 million in the first half of 2026, and the adjusted EBITDA margin increased to 25.10 percent from the prior-year level. Adjusted free cash flow reached EUR 68.0 million, up 70.00 percent year over year. These figures put operating execution alongside the larger acquisition timetable.

Three dates shape the transaction

On March 16, 2026, Amplifon announced the EUR 2.3 billion GN Hearing acquisition, according to Rankia. On May 22, 2026, the company placed 45.3 million new shares at EUR 10.00 each, raising EUR 453 million before costs, the same source reported. On October 8, 2026, Amplifon published valuation documents for the transaction, with the shareholder meeting set for October 29, 2026, according to Amplifon Corporate.

What will October 29 test?

The third-quarter and nine-month report is scheduled for October 29, 2026, alongside the extraordinary and ordinary shareholder meeting. Investors will receive a new operating checkpoint while shareholders consider steps linked to the GN Hearing transaction, including the planned issuance of 56 million shares.

Market value and next step

Amplifon had a market capitalization of EUR 2.8 billion as of October 21, 2026. The company is listed on Euronext Milan and belongs to the FTSE MIB, while the October 29 appointments combine earnings evidence with a corporate decision.

Amplifon was trading at EUR 12.77 at Lang & Schwarz on October 21, 2026 at 10:38 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Amplifon stock.